Skip to content

Change and repeatability of heart rate by acupuncture stimulation Evaluation by heart rate variability analysis in man

Change and repeatability of heart rate by acupuncture stimulation Evaluation by heart rate variability analysis in man - Change and repeatability of heart rate by acupuncture stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047940
Enrollment
20
Registered
2022-06-06
Start date
2022-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy condition

Interventions

The site of acupuncture stimulation is the left-side Hegu (LI4) point on the outside the midpoint of the second metacarpal bone. The acupuncture stimulation is applied by the sparrow pecking method
that is, the acupuncture needle is inserted and move vertically at the frequency of 1 Hz at a depth of 15-20 mm for 90 seconds. Disposable stainless steel needles (40 mm , 0.20 mm) are used.

Sponsors

Teikyo Heisei University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Healthy person aged 20 and under 30 2) Those who can attend the study site within the study period 3) Persons who can get written consent for participation in this study

Exclusion criteria

Exclusion criteria: 1) Persons who go to the hospital or take medication for basic diseases (chronic respiratory diseases, heart diseases, kidney diseases, liver diseases, diabetes, blood diseases (hyponatremia, difficult-to-treat high blood pressure, etc.), immune function Decreasing illnesses (including malignant tumors), neurological disorders, neuromuscular disorders and severe mental illnesses) 2) Persons with extremely short sleep (less than 5 hours a day) and those with long sleep (10 hours or more a day) 3) Persons who complain of poor physical condition due to sleep disorders 4) Persons who have a habit of excessive smoking * 1 and excessive alcohol intake * 2, and those who have an extremely irregular diet * 3 5) Persons with significant abnormalities in blood pressure, blood test, urine test, etc. 6) Those who donated 400 ml of blood within 12 weeks, 200 ml of blood within 4 weeks, and component blood within 2 weeks before the start of the experiment 7) Persons participating in other clinical trials <Notes> * 1 Excessive smoking generally means smoking 21 or more cigarettes a day. * 2 Excessive alcohol intake is roughly equivalent to 2 cups of sake per day (500 ml of beer bottle x 2 bottles, whiskey double 60 ml x 2 cups, 1 go of shochu 180 ml, 1 cup of red wine glass 60 ml x 7 cups) or more. Refers to drinking. * 3 Refers to a state in which one or more meals a day are one or more meals, and the meal time is constantly irregular.

Design outcomes

Primary

MeasureTime frame
Measurement of electrocardiogram: Electrodes are placed on the chest induction I and recordings are made. The instantaneous heart rate is calculated from the R-R interval of the recorded ECG. In addition, HRV analysis is performed as an indicator of cardiac autonomic function. The ECG is measured for 5 minutes before stimulation, 90 seconds during stimulation, and 5 minutes after stimulation, for a total of 11 minutes and 30 seconds.

Secondary

MeasureTime frame
Assessment of the type of pain: The presence or absence of "pain" or "de qi" during the stimulation will be assessed after the end of the experiment. Evaluation of the degree of pain: The intensity of the "pain" or "de qi" is assessed using a visual analogue scale (VAS) of 10 cm in width, respectively, with 100 points as the most intense pain on a scale of every 1 mm, and 0 as the scale indicating no pain.

Countries

Japan

Contacts

Public ContactNamiki Shinozaki

Teikyo Heisei University Department of Acupuncture and Moxibustion, Graduate School of Health Sciences

n.shinozaki1@gmail.com080-7698-1412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026